Home 
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023 |
||
| Title: Surgery for cardiac myxomas: 12-year experience | ||
| Author: Ivo GASPAROVIC, Panagiotis ARTEMIOU, Branislav BEZAK, Stefan MICHUT, Michal HULMAN | ||
| Abstract: INTRODUCTION: Cardiac myxoma is a rare benign cardiac tumor observed in approximately 0.5–1 case per 1 million people per year. The aim of this study is to review our 12-year experience in the surgical treatment of cardiac myxoma with an emphasis on the clinical, pathologic, diagnostic, and surgical features. METHODS AND PATIENTS: From January 2010 to December 2022, 90 patients (0.67 %) with cardiac myxomas were surgically treated in our institute. Patients´ demographics, cardiac and surgical medical history, surgical procedures, and pre- and post-operative data were analyzed. The median follow-up time was 76 (1–216) months. RESULTS: The mean age of the patients was 59.4 ± 13.5 years, with a higher prevalence of women. The most common preoperative symptoms were arterial embolism and dyspnea, and 35.6 % of patients were asymptomatic. Only 8.9 % of the patients had systemic and constitutional manifestations. The most common location of cardiac myxoma was in the left atrium, followed by the right atrium. Recurrent myxoma developed in 3 patients (2.7 %), and the mean time of recurrence was 55 ± 19.7. Hospital and long-term mortality were 2.2 % and 15.6 %, respectively. CONCLUSION: Cardiac myxoma is the most common heart tumor with a low incidence. Surgical excision yields very good short and long-term outcomes with low recurrence rate after surgery, and remains the treatment of choice (Tab. 4, Fig. 2, Ref. 13). Text in PDF www.elis.sk |
||
| Keywords: cardiac myxoma, cardiac tumor, recurrence, survival | ||
| Published online: 04-Jul-2023 | ||
| Year: 2023, Volume: 124, Issue: 9 | Page From: 635, Page To: 638 | |
| doi:10.4149/BLL_2023_098 |
||
|
|
 download file |
|